Newly Diagnosed Higher Risk Myelodysplastic Syndrome clinical trials

Explore recruiting newly diagnosed higher risk myelodysplastic syndrome clinical trials.

Recruiting newly diagnosed higher risk myelodysplastic syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Newly Diagnosed Higher Risk Myelodysplastic Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Global Multicenter, Double-Blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination with Azacitidine (AZA) in Patients with Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4)

Poland, Italy, Greece, Czechia, Bulgaria, Hungary +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Newly Diagnosed Higher Risk Myelodysplastic Syndrome trials by city

Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Toronto Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Vancouver Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Montreal Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Calgary Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Edmonton Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Ottawa Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Winnipeg Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Quebec City Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Hamilton Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Kitchener Newly Diagnosed Higher Risk Myelodysplastic Syndrome in London Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Halifax Newly Diagnosed Higher Risk Myelodysplastic Syndrome in New York Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Los Angeles Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Chicago Newly Diagnosed Higher Risk Myelodysplastic Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease